Stock A237880 CLIO COSMETICS CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Ratings CLIO Cosmetics Co.,Ltd

Equities

A237880

KR7237880000

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-27 pm EDT 		5-day change 1st Jan Change
38,250 KRW +0.53% Intraday chart for CLIO Cosmetics Co.,Ltd +1.73% +24.19%
Apr. 19 CLIO Cosmetics Co.,Ltd agreed to acquire Doowon for KRW 7.05 billion. CI
Mar. 21 CLIO Cosmetics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • Its core activity has a significant growth potential and sales are expected to surge, according to Standard & Poor's' forecast. Indeed, those may increase by 54% by 2026.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
  • For several months, analysts have been revising their EPS estimates roughly upwards.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Over the past four months, analysts' average price target has been revised upwards significantly.

Weaknesses

  • The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
  • The average consensus view of analysts covering the stock has deteriorated over the past four months.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Personal Products

1st Jan change Capi. Investor Rating ESG Refinitiv
CLIO COSMETICS CO.,LTD Stock CLIO Cosmetics Co.,Ltd
+24.19% 493M -
L'ORÉAL Stock L'Oréal
-1.89% 259B
B-
KAO CORPORATION Stock Kao Corporation
+18.81% 20.66B
B+
GALDERMA GROUP AG Stock Galderma Group AG
0.00% 19.04B - -
SHISEIDO COMPANY, LIMITED Stock Shiseido Company, Limited
+17.33% 12.68B
A-
COTY INC. Stock Coty Inc.
-13.77% 9.25B
A-
AMOREPACIFIC CORPORATION Stock Amorepacific Corporation
+23.03% 8.07B
B+
PROYA COSMETICS CO.,LTD. Stock Proya Cosmetics Co.,Ltd.
+11.07% 6.01B
B
NATURA &CO HOLDING S.A. Stock Natura &Co Holding S.A.
-12.20% 3.98B
B+
INTER PARFUMS, INC. Stock Inter Parfums, Inc.
-16.08% 3.87B
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
  1. Stock Market
  2. Equities
  3. A237880 Stock
  4. Ratings CLIO Cosmetics Co.,Ltd